Welcome, Guest
You have to register before you can post on our site.

Username
  

Password
  





Search Forums

(Advanced Search)

Forum Statistics
» Members: 2,795
» Latest member: kidwinj
» Forum threads: 7,059
» Forum posts: 123,415

Full Statistics

Latest Threads
Odds and Ends ... With So...
Forum: The Lounge
Last Post: IceWizard
11-13-2026, 01:20 AM
» Replies: 11
» Views: 3,032
Here are a couple I found
Forum: IOPList Suggested IOP's
Last Post: gujjernoran
11-12-2026, 08:26 PM
» Replies: 1
» Views: 759
www.MacroMass.COM.PH
Forum: IOPList (Approved & Recommended)
Last Post: Macro Mass
11-11-2026, 04:56 PM
» Replies: 3,854
» Views: 7,123,061
The Juke Box is OPEN
Forum: The Lounge
Last Post: Mr. HIND
11-09-2026, 08:03 AM
» Replies: 2,939
» Views: 1,651,515
MOVIES
Forum: The Lounge
Last Post: IceWizard
11-09-2026, 05:10 AM
» Replies: 147
» Views: 48,520
www.MacroMass.COM.PH
Forum: IOP Discounts, Offers & More
Last Post: Macro Mass
11-08-2026, 09:07 PM
» Replies: 143
» Views: 79,732
Humorous Smilies
Forum: The Lounge
Last Post: IceWizard
11-02-2026, 01:22 AM
» Replies: 4,936
» Views: 4,246,877
Deaths So Far (and it's j...
Forum: World News
Last Post: IceWizard
10-31-2026, 07:15 PM
» Replies: 51
» Views: 14,383
'Biscuit' the dog is late...
Forum: World News
Last Post: IceWizard
10-31-2026, 06:16 PM
» Replies: 0
» Views: 136
GAME - Change one word ga...
Forum: The Lounge
Last Post: IceWizard
10-15-2026, 05:21 AM
» Replies: 2,142
» Views: 1,012,706

 
  Well, I got my first Love Letter . . .
Posted by: josegonzalez - 06-27-2018, 10:29 PM - Forum: IOP General Discussion - Replies (25)

Well, I got a notice regarding something ordered about a month and a half ago.   Angry

Is there anything specific I can post that might be helpful or of interest to others w/out breaking any rules?

Print this item

  Hello good people of this community!
Posted by: sweet77 - 06-27-2018, 05:43 AM - Forum: Welcome - Replies (11)

I'm taking it all in and yeah it seems like in some ways  words can be dangerous if not properly processed better one hits enter. words should be chosen carefully , as not to ruin a good thing.

Print this item

  Greetings from another newbie
Posted by: surfergirl - 06-27-2018, 12:40 AM - Forum: Welcome - Replies (13)

So glad to be here, thank you for creating such a great resource for us self-help types. Will be working on posting to get my reputation score up - kind of daunting for a chronically ill bed-bound person with low energy. Any tips on where best to post? I prefer not to do redundant senseless posting if possible, I'm too OCD for that  Smile  Thanks everyone!  Heart

Print this item

  U.S. approves first marijuana plant-derived drug for epilepsy
Posted by: Linville - 06-25-2018, 11:08 PM - Forum: World News - Replies (10)

U.S. approves first marijuana plant-derived drug for epilepsy
[color=var(--body-font-color)]Tamara Mathias[/color]

[color=var(--body-font-color)]https://www.reuters.com/article/us-gw-ph...SKBN1JL299[/color]

(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc’s epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.
 
FILE PHOTO: A flowering marijuana plant. REUTERS/Chris Wattie

The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), rare childhood-onset forms of epilepsy that are among the most resistant to treatment. 

“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said Food and Drug Administration Commissioner Scott Gottlieb. 

The drug, Epidiolex, is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and contains less than 0.1 percent of tetrahydrocannabinol (THC), the psychoactive component that makes people high. 

GW Pharma grows its own supply of cannabis in specialized glass houses in the United Kingdom to ensure uniformity in the genetic composition of the plants, which are then processed into a liquid solution of CBD. 

Although THC can induce paranoia, anxiety and hallucinations, CBD has the opposite effect and has been cited by scientists as a potential treatment for mental health issues. 

While supporters of legalizing marijuana say the decision is a step in the right direction, businesses reliant on the plant must contend with the federal government’s ban on its use. 
Based on the potential for abuse, the Drug Enforcement Administration (DEA) categorizes chemicals into five schedules, with Schedule 1 substances - like marijuana and heroin - considered the most deadly and deemed to have no medical benefits. 

As a result, Epidiolex’s launch remains at the discretion of the DEA, which must now evaluate the drug and consider reclassifying it as a substance that has medical properties, so as to allow GW to begin selling it. 

GW said it expects the reclassification to occur within 90 days. The company has not yet set a price for the drug and said it would work with insurance providers to ensure the medicine would be covered under health plans. 

GW’s Nasdaq-listed shares marginally fell in afternoon trading. The stock has run up nearly 50 percent in the past 12 months. 

Most patients with LGS and DS require multiple seizure medications and the majority are resistant to currently approved anti-epileptic drugs. 

The two epilepsy forms are severe and associated with high rates of mortality. Some LGS patients have to wear helmets to avoid brain injuries from “drop seizures”, where muscles suddenly become limp and cause standing patients to collapse. 

Epidiolex would also be the first approved therapy for DS, treatments for which are currently limited to a combination of seizure medication and drugs to prevent emergencies. 

Treatments available for both disorders are far from perfect and some patients resort to buying “self-prescribed” CBD online or from unregulated vendor sites, Dr. Pavel Klein, founder of the Mid-Atlantic Epilepsy and Sleep Center, said. 

“I hope patients have conversations with their physicians about whether this product (Epidiolex) provides them with treatment they have been looking for with other unapproved products,” said Douglas Throckmorton, deputy director of regulatory programs at the FDA’s Center for Drug Evaluation and Research. 

Reporting by Tamara Mathias and Manas Mishra in Bengaluru; Editing by Shailesh Kuber and Arun Koyyur

Print this item

  Tramadol: the BEST anti-depressant
Posted by: josegonzalez - 06-25-2018, 09:07 PM - Forum: IOP General Discussion - Replies (8)

I've been on many annti-depressants over my lifetime, but nothing I've tried works as good as tramadol.  I find that even just one 50mg capsule per day keeps the blues away.  It seems odd to me that just because it contains a minor synthetic opioid it's not prescribed for this purpose.   Angry

Print this item

  Great Article; On The Science of Addiction
Posted by: Linville - 06-24-2018, 10:17 PM - Forum: Addiction & Recovery - Replies (1)

Maybe the best I have ever read.

=============


The science of addiction: How opioids — and environment — change the brain


[color=var(--body-font-color)]Kristi L NelsonUpdated 5:02 p.m. ET Feb. 2, 2018[/color]
Dr. Stephen Loyd describes the biggest issue with opioid addiction: cravings.Brianna Paciorka/News Sentinel
In March, Stephen Loyd was scrolling through Google images for a PowerPoint presentation on addiction when a picture of a bottle of Percocet pills triggered a powerful craving.
His mouth watered. His hand trembled. He couldn’t move the computer mouse.

When it happened, Loyd was in his office on the sixth floor of a government building in downtown Nashville, where he serves as medical director for Substance Abuse Services for the state of Tennessee, one of the states hardest hit by the opioid epidemic.

And he has been clean 13 years.
COMPLETE COVERAGE: The science of opioids

That’s how powerful opioid cravings are, Loyd said. And cravings are the primary reason it’s so hard to treat opioid addiction.

“The reason people relapse is the cravings,” Loyd said. “The cravings are persistent for the rest of your life. … I always wonder, when I tell this, if people get nervous. I’m the medical director for the whole state. The medical director for the state of Tennessee still gets cravings for opioids? He does.”

How opioids trick the brain
The human brain is designed to reward you with feelings of pleasure when you engage in activities that benefit our species: eating, exercising, sex. When part of the brain — the ventral tegmental area — is signaled that you’re doing these things, it triggers another part of the brain — the nucleus accumbens — to release the chemical dopamine. Brain cells sensitive to dopamine receive it and generate a feeling of pleasure. Meanwhile, other parts of the brain form a memory of what happened to produce that pleasurable feeling.

Opiate drugs, which come from the opium poppy flower, and synthetic, or man-made, opioids also can trigger that brain process in the mesolimbic system. The drugs attach to certain specialized proteins on the same receptor brain cells where the pleasure-causing chemicals the body naturally makes normally attach. So can other drugs, including alcohol — but the body seems to develop a tolerance to opioid drugs more quickly.

That is, it develops a tolerance for the drugs’ abilities to relieve pain or produce pleasure, requiring an increasingly higher amount to fire up the process that produces dopamine, said neuropsychiatrist Dr. Richard Gibson, an addiction specialist who practices, teaches and conducts research at the University of Tennessee Medical Center in Knoxville.

However, Gibson said the body doesn’t develop a tolerance to the amount of drugs needed to depress the respiratory system — which is how most opioid users fatally overdose.
Gibson said opioids can physically change the structure of the brain. That concept of “plasticity” was foreign when he went through medical school in the 1960s.

“We thought the brain was unchanging,” Gibson said. “It turns out the brain can remodel itself quite well in a lot of circumstances” — for better or worse.

Dropped signals, bad judgment
Among the changes that can occur is a disconnect between the part of the brain responsible for insight and judgment — the prefrontal cortex — and the mesolimbic “reward center” that triggers the release of dopamine, Loyd said.

Ordinarily, the prefrontal cortex sends signals to that reward center. The result: the ability to use judgment to restrain bad impulses.

“We do it all the time — we kind of play through scenarios and pick the one that has the most benefit and the least consequences,” Loyd said.

But studies have suggested drug abuse not only could lower the level of the chemical used to transmit those signals, but also could damage the particular circuit that carries the signals from the prefrontal cortex to the reward center. In fact, Loyd said some studies suggest those connections stop developing at the age of first drug use —

“so you can have somebody who’s 35 years old, and they’re making decisions like a 12-year-old.”

Those connections can re-form, Loyd said, but it takes time — about 18 months to two years for most people.

That’s why he argues that detox alone — getting addicts over the hump of terrible withdrawal symptoms, which range from a few days to a few weeks, depending on the drug — isn’t enough to ensure they’ll stay clean. Putting people through detox and then turning them back out on the streets is like “sticking them out there with a half a brain,” he said. Since the prefrontal cortex still isn’t functioning normally, “they’re driven solely by rewards, they’re having cravings, and they’re going to relapse 99 times out of 100.”

Why do doctors and pilots do better?
For years, Loyd wore rubber bands around his wrists like bracelets. Few people knew their purpose — it was so he could “snap” his wrist if he felt a drug craving coming on, interrupting the “loop” of fixating on the drug, how it would make him feel and how to get it. Having interrupted the loop, he could then move through the process he knew would keep him from seeking a high: call a buddy, talk about the impulses, engage the prefrontal cortex to remind him of all he had to lose.

Loyd didn’t automatically learn this process. It was, in a sense, a byproduct of his profession. At the time he became addicted, Loyd was a practicing internal medicine physician. After detoxing in a major research hospital, he went into a 90-day inpatient addiction treatment program that accepted only medical professionals and fully prepared him to deal with cravings afterward, teaching him to recognize the onset and reach out for help. It came with five years of aftercare.

In contrast, most people who do manage to get expensive inpatient treatment get, at most, 28 days, Loyd said. Even those people are a tiny fraction of people who need it. A 2015 report by the federal Substance Abuse and Mental Health Services Administration estimated only 10.8 percent of the people who needed substance abuse treatment got any — inpatient, outpatient or even detox.

In various studies, the five-year sobriety rate for opioid addicts ranges from less than 10 percent to about 30 percent. But among doctors and airline pilots, who get intensive inpatient treatment and aftercare, it’s 75 percent to 90 percent, Loyd said.
“We don’t do that well with strep throat!” he said.

Pilots and physicians are examples of high-pressure, high-paying professions. While they may have more resources than average people, they’re also harder to replace — so there’s a vested interest in returning them to the same jobs in which they might have become addicted.

In the case of commercial airline pilots, the Federal Aviation Administration oversees an intensive peer-reported treatment program, the Human Intervention Motivation Study (HIMS), which began in the 1970s, then sponsored by the Air Line Pilots Association International labor union and funded by the National Institute for Alcohol Abuse and Alcoholism. Through the program, most pilots get about a month of inpatient treatment and about three years of follow-up recovery treatment, along with several years of close monitoring for relapse.

For doctors, most states — including Tennessee — have a physician health program that intervenes when doctors are facing mental health or substance abuse issues. The doctor is evaluated, and case managers in the physician health program make recommendations for treatment; the doctor pays for the recommended treatment. 
After treatment, the physician health program and treatment program make ground rules for the doctor’s re-entry into practice, establishing a contract with the doctor based on their recommendations. 
Follow-up care usually lasts about five years.

“So, we know the model” for long-term sobriety, Loyd said.
What’s lacking is the funding to provide that type of intensive inpatient treatment to the broader population of addicts.

‘Leveling the field’ with medications
That’s where medication-assisted therapy comes in, Loyd said: “It levels the playing field.”
Methadone, a long-acting narcotic painkiller, fits into the same brain receptors as opioids but doesn’t produce the euphoric “high” the opioid drugs do. It also can block opioids from attaching to the receptors, if a person relapses and takes an opioid after having taken methadone.

Naltrexone, approved to treat opioid addiction in 1984 and alcohol addiction in 1994, binds to the receptors and blocks them altogether so that opioids can’t attach. Because naltrexone doesn’t activate the receptors at all, though, it won’t prevent withdrawal symptoms, and patient compliance with taking it regularly has historically been low. 

In recent years, naltrexone has been available in an injection — Vivitrol — that’s taken once a month.
Buprenorphine — sometimes combined with naloxone in Suboxone — fits into the opioid receptors, but it’s not a perfect fit, so the receptor only partially “fires.” The body is tricked into thinking it has opioids, but buprenorphine won’t produce a euphoric high or depress the respiratory system.

The three drugs, available by prescription only, are doled out under a doctor’s supervision. Treatment can be expensive — around $500 a month for cash-paying patients to get an office visit and fill the prescription.

While many people “have very strong moral feelings” against using replacement drug therapy with someone who’s addicted, “there’s a lot of evidence it’s one of the more effective harm-reduction strategies in all of medication,” Gibson said.
At one year after starting medically managed treatment, Gibson said, three-quarters or more of opioid addicts haven’t relapsed; for an abstinence-only program, the success rate is less than 20 percent.

The medications’ “utility is, they quell cravings, and now you’ve got time to hold people in treatment and teach them the skills they need to manage cravings and stay clean going forward,” Loyd said.

Managing cravings is key to long-term success. Powerful cravings can happen suddenly after years of sobriety, the brain reacting as though the body will go into withdrawal if it doesn’t get opioids, Gibson said. Scientists have investigated whether a trace of opioids could be stored somewhere in the brain, emerging randomly, but “every evidence we have suggests this is not possible,” he said.

Instead, most researchers think a cued reminder “triggers” a physical craving — an image, sound, scent. When scientists put a crack addict in a scanner that looks at brain chemistry and flashed a photo of a crack pipe for 33-thousandths of a second — too quickly for him to even be aware he saw it — the image showed a definite reaction in the mesolimbic reward center of the brain.

“It’s like a ticking time bomb for some people,” Gibson said.

Genetics + environment = increased risk
Addictionology isn’t an exact science. Scientists aren’t sure yet, for example, what role genetics play, but it’s clear having a family history of addiction may predispose a person to become addicted.

Environment, too, plays a big part, especially stressors. Men are more likely than women to become addicted to opioids, but scientists don’t know if that’s because of a physical difference in the way the body reacts to drugs, a psychological difference in how men and women handle stress or temptation, or some combination. Several studies suggest up to 75 percent of people who abuse opioids were victims of physical or sexual abuse, with women more likely than men to have been abused.

The landmark 1995 CDC-Kaiser Permanente Adverse Childhood Experiences Studylinked adverse childhood experiences — ACEs — directly with significantly increased risk of heart disease, cancer, mental illness, violence, suicide — and addiction.

ACEs can include physical, emotional and sexual abuse; physical and emotional neglect; living with a family member with addiction or other mental illness; living through parents’ divorce or separation; having an incarcerated family member; witnessing a family member being abused; being homeless; being bullied or living in an unsafe neighborhood or a war zone; and being in the foster-care or juvenile detention systems. 

The study found that the more types of adversity a child experienced, the higher the risk of these physical and mental issues. People who experienced five or more types of trauma were seven to 10 times more likely to use illegal drugs — including injecting them — and to report being addicted.

Dr. Daniel Sumrok, director of the Center for Addiction Sciences at the University of Tennessee Health Science Center’s College of Medicine in Memphis, said the “trauma of childhood” absolutely can cause “neurobiological changes.” He estimates 90 percent of his clients have had three or more ACEs.

In two outpatient clinics, Sumrok combines medication-assisted therapy with therapy to address those childhood traumas. Drug use, he believes, is actually “ritualized compulsive comfort-seeking”; part of his job is to help patients replace it with a safer, legal coping behavior.

Studies suggest that chronic stress during childhood can physically change the developing brain, shrinking the parts that process emotions, manage stress, control impulses, weigh decisions and deal with fear. As a result, as adults, children who had ongoing traumatic experiences may have more fear and anxiety related to even minor stressors, as well as more susceptibility to depression and mood disorders.

Sumrok, an Army veteran himself, spent the early part of his career researching the symptoms of post-traumatic stress disorder — including substance abuse — in Vietnam veterans, eventually concluding it’s not a “disorder” but rather a normal learned response to trauma.

Gibson was in the U.S. Navy when Veterans Affairs and Department of Justice began preparing for an expected onslaught of soldiers returning home from Vietnam addicted to heroin. 
Heroin was easy to get in Vietnam, and the government knew soldiers were taking it: 
Around 20 percent of returning soldiers said they were addicted.

Turns out, “when people were not in Vietnam anymore, and they weren’t in danger of being killed every day … the need for opioids was pretty much gone,” Gibson said. “People had some mild effects, but nothing like the degree of addiction that was thought to be present. … 

This led to a lot of insights into opioid addiction” — specifically, the impact of changing addicts’ environment and routine to help them get clean.

Addiction is as much a social problem as a scientific one, Loyd said. Sending a detoxed addict back into the situation that led to addiction is certain to backfire. The numbers bear out the need for follow-up, he said. An opioid addict who stays clean for one year has a 10-18 percent chance of making it to 15 years of sobriety.

“If you can get them to five years (clean), though, that jumps up to 65 percent,” he said. “It’s a dramatic difference. … The key is keeping them engaged in treatment.”

The Science of Opioids: Related stories

• Drugs kill more Americans than drugs, cars and AIDS. How we got here.
• Judge: Stop the legal fights and curb the opioid epidemic     
• States curb pain pill prescribing to try to prevent opioid addiction
• With 175 Americans dying a day, what are the solutions to the opioid epidemic?     
• The science of addiction: How opioids — and environment — change the brain
• If opioids are not the answer to treating chronic pain, what is?
• How the FDA helped pave the way for an opioid epidemic
• Could painkillers cause cancer patients' tumors to grow?
• History repeats itself with opioid epidemic

Print this item

  https://www.etizolab.com
Posted by: Richardg8092 - 06-24-2018, 06:37 AM - Forum: Random Suggest IOP's - Replies (12)

Has anyone heard of this crew?   https://www.etizolab.com

I've done a broad search within IPList but I couldn't find a reference to them.
The site appears legit (but of course, don't they all....?  Wink )

I would be interested to know if anyone has accessed their products with success and can vouch for their stealthiness.
With Thanks,
R.

Print this item

  1st Post-The New Person
Posted by: Mr. HIND - 06-24-2018, 12:51 AM - Forum: Welcome - Replies (15)

Hello folks,
This is my first post and hopefully I can keep up with the conditions to meet 50 posts. I'm pushing 50 yrs old and have quite a bit of experience with the up's N downs of the 'subscription' life. Past several months I've had 3 VIP subscriptions close down so I'm back to square one, which can be unsettling at times. I have to admit I've poked around in these forums in the past for feedback and it helped me out, so I'd like to add a Thank You for doing me a solid.

Glad these forums are here and understand why the rules are what they are. For my own sake i'm going to go over the rules some more till I feel comfortable as I hate making mistakes.

Thank you

Print this item

Tongue Hello again..I’m back
Posted by: Undermedicated - 06-23-2018, 03:09 PM - Forum: Welcome - Replies (9)

Hello everyone just wanted to come introduce myself and say hello to old friends. I’ve actually been a member here since the beginning but have been to busy to be very active. I’ve known Charon (I actually know her as River) for probably 10years now maybe. I was very active on the old ioplist and several other places. I used to go by Flipmastermike.
I have been using iops since the early 2000’s. So I have a pretty vast knowledge and experience in this field. So I am here to help in anyway I can. 
Although I have absolutely zero knowledge on what’s going on in the iop world the last year. So I am also here to learn.
Just placed an order with Doc a couple days ago without doing any recent research so hope they are still good to go Big Grin  I always research first but this time I said screw it and placed the order since they have always been good in the past and hopefully still are lol.

Nice to be back here!

Print this item

  anyone tried cbt e juice
Posted by: cmdline - 06-23-2018, 12:24 PM - Forum: Medical Marijuana - Replies (3)

seen this juice being sold now for over a year all over vape shops and what not, at ridicilous prices, anyway to cut it short went on holidays and found a spot that had it sold and said why not 13$ a bottle, guy selling was pharmacist and gave me usual no high on this only for pain and anxiety.

but giving it several good go's found it smells sort of mj and gives throat burn but no relief in either pain or anxiety, not sure what strength ive gotten think its like 50mg per 15ml 99% pure, but reading online i find topics that 90%+ claim its snake oil at best, sort of agree since single cannabinoid out of 100 chemicals in plant seems just to good to be true, now i know few people actually benefited with seizures and since its harmless its all fine all over globe as theres no active thc in it.

Anyhow if someone tried long term would like to hear stories, as industrial hemp seems just targetting those that might be falsely tricked really to its values as any health supplement, after personally trying it.

Print this item